Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377101 | 12537710 | 1 | I | 20160704 | 20160707 | 20160707 | EXP | US-MYLANLABS-2016M1028193 | MYLAN | IBRAHIM SA, ALBANY Z, ALBANY C. SIGNIFICANT RESPONSE TO LACOSAMIDE IN A PATIENT WITH SEVERE CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY. J-COMMUNITY-SUPPORT-ONCOL 2015;13(5):202-204. | 0.00 | Y | 0.00000 | 20160707 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377101 | 12537710 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | U | 81235 | |||||||||
| 125377101 | 12537710 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | U | U | 0 | |||||||||
| 125377101 | 12537710 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 70 MG/M2 ON DAY 1 | U | U | 0 | ||||||||
| 125377101 | 12537710 | 4 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | U | U | 0 | |||||||||
| 125377101 | 12537710 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | 1,000 MG/M2 DAYS 1 AND 8 EVERY 21 DAYS | U | U | 0 | ||||||||
| 125377101 | 12537710 | 6 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125377101 | 12537710 | 1 | Transitional cell carcinoma |
| 125377101 | 12537710 | 2 | Transitional cell carcinoma |
| 125377101 | 12537710 | 4 | Transitional cell carcinoma |
| 125377101 | 12537710 | 5 | Transitional cell carcinoma |
| 125377101 | 12537710 | 6 | Transitional cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125377101 | 12537710 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125377101 | 12537710 | Nausea | |
| 125377101 | 12537710 | Neuropathy peripheral | |
| 125377101 | 12537710 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |